Off-label Use Of Approved Drugs To Treat COVID-19
Summary
The bill specifies that: A physician, physician assistant, or advanced practice registered nurse with prescriptive authority may prescribe and dispense, and a pharmacist may dispense, therapeutic drugs for off-label use, including hydroxychloroquine sulfate and ivermectin, to provide prophylaxis or outpatient (at-home) and inpatient (hospital) treatment to an individual with COVID-19; and This practice is not unprofessional conduct or otherwise grounds for discipline.(Note: This summary applies to this bill as introduced.)
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2022
Committee Review
Floor Vote
Governor
Introduced Jan 12, 2022
Last action Mar 16, 2022
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
1
Committee
1
Mar 16, 2022
Lower · Passed
House Committee on Health & Insurance Postpone Indefinitely
lower
Jan 12, 2022
Introduced
Introduced In House - Assigned to Health & Insurance
lower
3 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Dennis Hisey
RRepublican
P
Jerry Sonnenberg
RRepublican
P
Stephanie Luck
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 22-1015
Scope: CO
Hi! I can help you understand HB 22-1015. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline